Cancer Incidence and Mortality for Chenango County, 2015-2019

Source: New York State Cancer Registry

Site of Cancer Incidence Mortality
Males and Females Males Females Males and Females Males Females
Average Annual Cases Rate per 100,000 Population 95% CI Average Annual Cases Rate per 100,000 Males 95% CI Average Annual Cases Rate per 100,000 Females 95% CI Average Annual Deaths Rate per 100,000 Population 95% CI Average Annual Deaths Rate per 100,000 Males 95% CI Average Annual Deaths Rate per 100,000 Females 95% CI
All Invasive Malignant Tumors 354.4 515.6 490.7-541.6 182.4 530.6 495.4-567.9 172.0 509.1 473.3-547.0 114.6 159.3 146.2-173.5 58.6 174.5 154.7-196.5 56.0 149.9 132.1-169.7
Oral cavity and pharynx 10.4 14.8 10.9-19.9 7.4 21.8 15.1-30.9 3.0 8.2 4.4-14.4 2.0 2.7 1.3-5.4 1.4 3.9 1.5-8.8 0.6 1.7 0.3-5.9
Esophagus 4.2 5.5 3.4-8.8 3.2 8.5 4.7-14.5 1.0 2.7 0.8-7.1 2.6 3.3 1.8-6.0 1.2 3.2 1.1-7.7 1.4 3.4 1.4-7.9
Stomach 2.8 4.4 2.3-7.9 1.0 3.2 0.9-8.3 1.8 5.6 2.4-11.4 1.8 2.8 1.2-5.7 1.2 3.6 1.2-8.8 0.6 1.9 0.4-6.2
Colorectal 30.0 44.2 37.1-52.4 14.6 45.5 35.2-58.1 15.4 43.4 33.9-55.0 8.8 12.8 9.2-17.5 3.8 11.9 7.0-19.2 5.0 13.8 8.8-21.0
Colon excluding rectum 23.0 33.8 27.7-41.1 10.4 33.0 24.2-44.2 12.6 34.7 26.4-45.1 7.8 11.5 8.1-16.0 3.0 9.3 5.0-16.1 4.8 13.4 8.5-20.5
Rectum & rectosigmoid 7.0 10.4 7.1-14.8 4.2 12.5 7.6-19.7 2.8 8.6 4.5-15.3 1.0 1.3 0.4-3.5 0.8 2.5 0.7-7.1 0.2 0.4 0.0-3.8
Liver / intrahepatic bile duct 4.0 5.1 3.1-8.2 2.6 6.6 3.5-12.1 1.4 3.6 1.4-8.2 2.6 3.6 1.8-6.6 1.6 4.1 1.7-8.9 1.0 3.2 0.9-8.3
Pancreas 10.4 14.3 10.6-19.0 5.4 15.1 9.8-22.6 5.0 13.4 8.6-20.4 10.4 14.3 10.7-19.1 6.0 17.9 11.9-26.1 4.4 11.0 6.9-17.4
Larynx 3.0 4.1 2.2-7.2 2.2 6.2 3.0-11.8 0.8 2.2 0.5-6.7 0.6 0.7 0.1-2.6 0.6 1.6 0.3-5.6 0.0 0.0 0.0-3.3
Lung and bronchus 54.2 73.4 64.6-83.2 28.2 77.8 65.2-92.5 26.0 70.4 58.3-84.5 32.4 44.4 37.7-52.2 16.0 45.6 36.0-57.3 16.4 43.9 34.6-55.3
Melanoma of the skin 15.6 23.9 18.6-30.3 9.4 31.1 22.5-42.0 6.2 17.6 11.6-25.8 1.2 1.5 0.5-3.6 0.6 1.6 0.3-5.6 0.6 1.3 0.3-5.1
Female breast             44.6 132.9 114.9-153.1             6.0 16.3 10.6-24.2
Cervix uteri             3.0 11.0 5.8-19.0             1.2 3.6 1.2-8.6
Corpus uterus and NOS             16.4 51.3 39.9-65.1             1.6 4.0 1.7-8.7
Ovary             4.4 13.8 8.3-21.9             2.0 4.9 2.3-9.8
Prostate       42.4 110.7 96.1-127.4             5.4 17.5 11.5-25.8      
Testis       0.6 3.4 0.7-9.4             0.2 0.5 0.0-3.9      
Urinary bladder (incl. in situ) 18.0 24.2 19.4-30.0 15.8 45.6 35.9-57.5 2.2 5.8 2.9-11.1 4.4 6.1 3.8-9.5 3.4 10.4 6.0-17.1 1.0 2.6 0.8-7.0
Kidney and renal pelvis 14.4 21.6 16.7-27.6 9.2 26.6 19.3-36.2 5.2 16.8 10.6-25.4 2.2 3.0 1.5-5.6 1.6 4.9 2.1-10.1 0.6 1.3 0.3-5.1
Brain and other central nervous system 5.4 10.5 6.8-15.7 2.8 11.2 6.0-19.2 2.6 10.2 5.1-18.0 3.0 5.4 2.9-9.2 2.0 7.1 3.4-13.5 1.0 4.0 1.1-9.9
Thyroid 11.2 20.8 15.4-27.6 3.0 10.3 5.5-17.8 8.2 32.0 22.3-44.3 0.4 0.6 0.1-2.5 0.4 1.4 0.2-5.5 0.0 0.0 0.0-3.3
Hodgkin lymphoma 0.6 0.8 0.2-2.7 0.4 1.1 0.1-5.0 0.2 0.4 0.0-3.9 0.0 0.0 0.0-1.6 0.0 0.0 0.0-3.3 0.0 0.0 0.0-3.3
Non-Hodgkin lymphomas 11.0 15.7 11.7-20.8 6.8 21.3 14.5-30.4 4.2 10.7 6.5-17.2 4.0 5.8 3.5-9.3 2.4 7.2 3.6-13.2 1.6 4.8 2.0-10.2
Myeloma 3.0 4.5 2.4-7.8 1.8 5.1 2.1-10.6 1.2 3.8 1.3-8.8 0.8 1.1 0.3-3.2 0.8 2.4 0.6-6.8 0.0 0.0 0.0-3.3
Leukemias 12.6 18.6 14.1-24.3 7.6 23.9 16.5-33.7 5.0 13.5 8.6-20.8 4.6 6.7 4.2-10.4 2.4 7.3 3.7-13.3 2.2 6.4 3.0-12.2

Notes

  • Incidence data are provisional, November 2021.
  • Rates are per 100,000 persons, age-adjusted to the 2000 US standard population, with 95% confidence intervals.
  • Rates based on fewer than 4 cases or deaths per year are unstable and should be used with caution. NOS = Not otherwise specified.